Stephen Davis, CEO: Acadia Pharmaceuticals ACAD Sell · Filed 23/02/27

Trade details

Type: Insider sale
Amount: $72,321.78
Shares · price: 3,851 sh · $18.78 a share
Held after: 91,727 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Stephen DavisCEO
Trade date: 23/02/24
Filed: 23/02/27
Days to filing: 3 days

Sold 4.0% of holdings

Share of holding sold: 4.0%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/25~23/03/26

Stephen Davis's recent trades

Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$485.1K
31,747 sh
$485.1K
Filed 24/08/20
Traded 24/08/19
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$193.6K
11,427 sh
$193.6K
Filed 24/05/03
Traded 24/05/02
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$316.6K
17,716 sh
$316.6K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$158.3K
8,858 sh
$158.3K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$317.1K
17,714 sh
$317.1K
Filed 24/03/27
Traded 24/03/27

Stephen Davis, CEO — sold $72.3K of Acadia Pharmaceuticals ACAD · 4.0% of holdings | Whalegun